| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Argonaute_N | 1.49e-04 | 4 | 94 | 2 | IPR032474 | |
| Domain | Argonaute_Mid_dom | 1.49e-04 | 4 | 94 | 2 | IPR032473 | |
| Domain | ArgoL2 | 1.49e-04 | 4 | 94 | 2 | IPR032472 | |
| Domain | ArgoN | 1.49e-04 | 4 | 94 | 2 | PF16486 | |
| Domain | ArgoMid | 1.49e-04 | 4 | 94 | 2 | PF16487 | |
| Domain | ArgoL2 | 1.49e-04 | 4 | 94 | 2 | PF16488 | |
| Domain | DUF1785 | 2.48e-04 | 5 | 94 | 2 | SM01163 | |
| Domain | Na_trans_cytopl | 3.71e-04 | 6 | 94 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 3.71e-04 | 6 | 94 | 2 | IPR024583 | |
| Domain | ArgoL1 | 3.71e-04 | 6 | 94 | 2 | PF08699 | |
| Domain | ArgoL1 | 3.71e-04 | 6 | 94 | 2 | IPR014811 | |
| Domain | PIWI | 6.88e-04 | 8 | 94 | 2 | PS50822 | |
| Domain | Piwi | 6.88e-04 | 8 | 94 | 2 | SM00950 | |
| Domain | Piwi | 6.88e-04 | 8 | 94 | 2 | PF02171 | |
| Domain | Piwi | 6.88e-04 | 8 | 94 | 2 | IPR003165 | |
| Domain | PAZ | 8.82e-04 | 9 | 94 | 2 | PS50821 | |
| Domain | PAZ | 8.82e-04 | 9 | 94 | 2 | SM00949 | |
| Domain | PAZ | 8.82e-04 | 9 | 94 | 2 | PF02170 | |
| Domain | PAZ_dom | 8.82e-04 | 9 | 94 | 2 | IPR003100 | |
| Domain | PDZ | 9.95e-04 | 151 | 94 | 5 | PS50106 | |
| Domain | PDZ | 1.03e-03 | 152 | 94 | 5 | IPR001478 | |
| Domain | Na_channel_asu | 1.10e-03 | 10 | 94 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 1.10e-03 | 10 | 94 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 1.10e-03 | 10 | 94 | 2 | PF06512 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 2.74e-05 | 37 | 67 | 4 | M29790 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 7.13e-05 | 47 | 67 | 4 | M29777 | |
| Pathway | BIOCARTA_DICER_PATHWAY | 2.20e-04 | 5 | 67 | 2 | M22079 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 2.47e-04 | 26 | 67 | 3 | M47923 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 3.15e-04 | 125 | 67 | 5 | M27186 | |
| Pathway | REACTOME_MICRORNA_MIRNA_BIOGENESIS | 3.30e-04 | 6 | 67 | 2 | MM14818 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 3.30e-04 | 6 | 67 | 2 | MM15083 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 4.60e-04 | 7 | 67 | 2 | M46421 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 4.61e-04 | 32 | 67 | 3 | M27900 | |
| Pathway | REACTOME_PTEN_REGULATION | 5.13e-04 | 139 | 67 | 5 | M27646 | |
| Pathway | REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS | 6.12e-04 | 8 | 67 | 2 | MM15082 | |
| Pathway | REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS | 7.84e-04 | 9 | 67 | 2 | M27340 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 7.84e-04 | 9 | 67 | 2 | M27810 | |
| Pathway | REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS | 7.84e-04 | 9 | 67 | 2 | M29809 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 7.84e-04 | 9 | 67 | 2 | M46436 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 8.94e-04 | 40 | 67 | 3 | MM15000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119 | 8.94e-04 | 40 | 67 | 3 | M47917 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 9.77e-04 | 10 | 67 | 2 | M48013 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.18e-03 | 44 | 67 | 3 | M27295 | |
| Pathway | BIOCARTA_PRC2_PATHWAY | 1.19e-03 | 11 | 67 | 2 | MM1548 | |
| Pathway | REACTOME_SUMOYLATION | 1.24e-03 | 169 | 67 | 5 | MM14919 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DENND4A PHACTR2 MYCBP2 RANBP3 LARP1 MPDZ SRGAP2 CBX4 CBL SYDE2 NEURL1 MACF1 TANC1 MTCL1 | 1.22e-07 | 861 | 97 | 14 | 36931259 |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.31e-06 | 123 | 97 | 6 | 26912792 | |
| Pubmed | ESPN GGNBP2 DENND4A PHACTR2 ACACB ZNF474 PCLO LARP1 DNAJB14 NCOR1 SCN9A MACF1 CCAR2 ITIH6 TOP1 SLC27A4 | 2.34e-06 | 1442 | 97 | 16 | 35575683 | |
| Pubmed | 3.10e-06 | 80 | 97 | 5 | 16094384 | ||
| Pubmed | 4.69e-06 | 87 | 97 | 5 | 12465718 | ||
| Pubmed | FKBP15 MYCBP2 NACA LARP1 MPDZ SRGAP2 MDC1 CCAR2 TANC1 HCFC1 SLC27A4 | 6.50e-06 | 733 | 97 | 11 | 34672954 | |
| Pubmed | 7.60e-06 | 96 | 97 | 5 | 17971504 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 32660355 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 1909870 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 24121496 | ||
| Pubmed | Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation. | 7.70e-06 | 2 | 97 | 2 | 3117546 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 24267955 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 22170718 | ||
| Pubmed | Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5. | 7.70e-06 | 2 | 97 | 2 | 3105095 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 17848572 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 27496708 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 28228532 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 15666817 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 17698910 | ||
| Pubmed | GGNBP2 ZNF142 ACACB BCL9 CBL CCDC85A NCOR1 TTBK2 NCOA1 MTCL1 | 1.21e-05 | 638 | 97 | 10 | 31182584 | |
| Pubmed | 1.47e-05 | 282 | 97 | 7 | 23667531 | ||
| Pubmed | 1.57e-05 | 396 | 97 | 8 | 26687479 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 12149646 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 19572376 | ||
| Pubmed | Thyroid hormone signaling in vivo requires a balance between coactivators and corepressors. | 2.31e-05 | 3 | 97 | 2 | 24550004 | |
| Pubmed | A reliable lacZ expression reporter cassette for multipurpose, knockout-first alleles. | 2.31e-05 | 3 | 97 | 2 | 15048813 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 18006628 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 33895391 | ||
| Pubmed | Regulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines. | 2.31e-05 | 3 | 97 | 2 | 26163549 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 20736324 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 26385605 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 28882566 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 12569182 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 17988216 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 23223495 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 9804773 | ||
| Pubmed | Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. | 2.31e-05 | 3 | 97 | 2 | 18302198 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 30689982 | ||
| Pubmed | 2.38e-05 | 549 | 97 | 9 | 38280479 | ||
| Pubmed | FKBP15 MED29 RBBP4 CBX4 PHC2 NCOR1 MDC1 UBXN7 CCAR2 JPT2 HCFC1 TOP1 | 2.59e-05 | 1014 | 97 | 12 | 32416067 | |
| Pubmed | 3.67e-05 | 446 | 97 | 8 | 24255178 | ||
| Pubmed | 4.22e-05 | 591 | 97 | 9 | 15231748 | ||
| Pubmed | ACACB NACA LARP1 BCL9 NCOR1 FBN2 AGO3 ZNF746 MDC1 UBXN7 NCOA1 CCAR2 HCFC1 TOP1 | 4.23e-05 | 1429 | 97 | 14 | 35140242 | |
| Pubmed | Molecular dissection of human Argonaute proteins by DNA shuffling. | 4.60e-05 | 4 | 97 | 2 | 23748378 | |
| Pubmed | Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. | 4.60e-05 | 4 | 97 | 2 | 15260970 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 22260870 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 15256534 | ||
| Pubmed | Argonaute proteins: potential biomarkers for human colon cancer. | 4.60e-05 | 4 | 97 | 2 | 20146808 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 9849963 | ||
| Pubmed | Slicing-independent RISC activation requires the argonaute PAZ domain. | 4.60e-05 | 4 | 97 | 2 | 22795694 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 11124027 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 18281521 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 26176234 | ||
| Pubmed | A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation. | 4.60e-05 | 4 | 97 | 2 | 10339548 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 19966796 | ||
| Pubmed | Nuclear receptor coregulator SNP discovery and impact on breast cancer risk. | 4.60e-05 | 4 | 97 | 2 | 20003447 | |
| Pubmed | A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor. | 4.60e-05 | 4 | 97 | 2 | 20543827 | |
| Pubmed | Importance of translation and nonnucleolytic ago proteins for on-target RNA interference. | 4.60e-05 | 4 | 97 | 2 | 18771919 | |
| Pubmed | A Requirement for Argonaute 4 in Mammalian Antiviral Defense. | 4.60e-05 | 4 | 97 | 2 | 32049003 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 4.70e-05 | 462 | 97 | 8 | 31138677 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 4.94e-05 | 341 | 97 | 7 | 32971831 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 5.70e-05 | 475 | 97 | 8 | 31040226 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 6.59e-05 | 357 | 97 | 7 | 37059091 | |
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 12526743 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 19393748 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 8812438 | ||
| Pubmed | Differential expression of components of the microRNA machinery during mouse organogenesis. | 7.66e-05 | 5 | 97 | 2 | 16036130 | |
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 12414724 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 18295596 | ||
| Pubmed | RING1 is associated with the polycomb group protein complex and acts as a transcriptional repressor. | 7.66e-05 | 5 | 97 | 2 | 9199346 | |
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 25712475 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 19324964 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 10803578 | ||
| Pubmed | 7.66e-05 | 5 | 97 | 2 | 14985122 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYCBP2 RBBP4 NACA LARP1 MPDZ SRGAP2 PHKA1 MACF1 CCAR2 JPT2 HCFC1 TOP1 | 8.59e-05 | 1149 | 97 | 12 | 35446349 |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 1.08e-04 | 167 | 97 | 5 | 20362541 | |
| Pubmed | 1.09e-04 | 268 | 97 | 6 | 33640491 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 17332741 | ||
| Pubmed | The ulcerative colitis marker protein WAFL interacts with accessory proteins in endocytosis. | 1.15e-04 | 6 | 97 | 2 | 20376207 | |
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 17468099 | ||
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 16373399 | ||
| Pubmed | Amino acids important for ligand specificity of the human constitutive androstane receptor. | 1.15e-04 | 6 | 97 | 2 | 15572376 | |
| Pubmed | p85beta phosphoinositide 3-kinase regulates CD28 coreceptor function. | 1.15e-04 | 6 | 97 | 2 | 19190244 | |
| Pubmed | The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. | 1.15e-04 | 6 | 97 | 2 | 9878542 | |
| Pubmed | 1.15e-04 | 6 | 97 | 2 | 21365123 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 1.15e-04 | 6 | 97 | 2 | 23652591 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.46e-04 | 283 | 97 | 6 | 30585729 | |
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 16606617 | ||
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 15788656 | ||
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 1.60e-04 | 7 | 97 | 2 | 19470757 | |
| Pubmed | Quantitative traits for the tail suspension test: automation, optimization, and BXD RI mapping. | 1.60e-04 | 7 | 97 | 2 | 17619104 | |
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 22863743 | ||
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 34907157 | ||
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 19131338 | ||
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 26074487 | ||
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 19536157 | ||
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 19383768 | ||
| Pubmed | 1.60e-04 | 7 | 97 | 2 | 15563468 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.71e-04 | 184 | 97 | 5 | 32908313 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 1.88e-04 | 565 | 97 | 8 | 25468996 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 1.59e-04 | 127 | 97 | 4 | chr2q24 | |
| Cytoband | 4q13 | 4.56e-04 | 15 | 97 | 2 | 4q13 | |
| GeneFamily | PDZ domain containing | 1.73e-04 | 152 | 62 | 5 | 1220 | |
| GeneFamily | Argonaute/PIWI family | 3.20e-04 | 8 | 62 | 2 | 408 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 4.10e-04 | 9 | 62 | 2 | 1203 | |
| GeneFamily | WAP four-disulfide core domain containing|Fibronectin type III domain containing | 1.71e-03 | 18 | 62 | 2 | 361 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.45e-03 | 181 | 62 | 4 | 694 | |
| Coexpression | GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN | 9.10e-06 | 200 | 96 | 7 | M7983 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYCBP2 SRGAP2 PTPRM RIN2 UBXN7 NAV3 NCOA1 AFF1 MACF1 BICRAL MTCL1 SETD3 TOP1 | 1.45e-05 | 856 | 96 | 13 | M4500 |
| ToppCell | Ciliated_cells-A-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 1.86e-06 | 170 | 96 | 6 | 8b7ef1464ea589886b575ebad5447b085cbdcdba | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.93e-06 | 171 | 96 | 6 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-06 | 184 | 96 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-06 | 184 | 96 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-06 | 184 | 96 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.13e-06 | 186 | 96 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 3.33e-06 | 188 | 96 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.44e-06 | 189 | 96 | 6 | cd4746ea6ae48a7dd14a2960d38d9445a738cf2c | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.44e-06 | 189 | 96 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.65e-06 | 191 | 96 | 6 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.65e-06 | 191 | 96 | 6 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.65e-06 | 191 | 96 | 6 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.65e-06 | 191 | 96 | 6 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.65e-06 | 191 | 96 | 6 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.76e-06 | 192 | 96 | 6 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 3.76e-06 | 192 | 96 | 6 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.88e-06 | 193 | 96 | 6 | bdb7401dd9059032f930f2b575f2ef8e504b6594 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 4.24e-06 | 196 | 96 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 4.24e-06 | 196 | 96 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.76e-06 | 200 | 96 | 6 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | PBMC-Mild-cDC_2|Mild / Compartment, Disease Groups and Clusters | 1.11e-05 | 135 | 96 | 5 | cb9d834f8301cf53f20e09c3f4cb6a148690196a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.59e-05 | 161 | 96 | 5 | f5df8c6a340d5026726804b103e32137f363ca40 | |
| ToppCell | IIF-Other-HSPC|IIF / Disease, Lineage and Cell Type | 2.75e-05 | 163 | 96 | 5 | 1e0d38fbed38ac48478868a1480172a1a3f7c1b7 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-05 | 165 | 96 | 5 | 34fd00be2b28716c871ad9fb356de84a299a0c01 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.27e-05 | 169 | 96 | 5 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-05 | 169 | 96 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 170 | 96 | 5 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-05 | 173 | 96 | 5 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-05 | 173 | 96 | 5 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.86e-05 | 175 | 96 | 5 | a84965d28438a4228d841b357c2cd75cf4b59a63 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-05 | 175 | 96 | 5 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.30e-05 | 179 | 96 | 5 | 61dbfc1b9b0344c06a68142c181cd62993556a67 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 4.32e-05 | 90 | 96 | 4 | adfd1c3238f19939c9ff850524d166f549c4b4c3 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 4.32e-05 | 90 | 96 | 4 | 2e324fd2d2faff2b073a2726747bd283deaa8b0a | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 4.32e-05 | 90 | 96 | 4 | 6ca41b5a618be50745bf8a83d697660847d04679 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.41e-05 | 180 | 96 | 5 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | Ciliated_cells-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 4.41e-05 | 180 | 96 | 5 | bdea5ec6b60fc8c7cce4d71db5da74ac8675e211 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.53e-05 | 181 | 96 | 5 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.53e-05 | 181 | 96 | 5 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.53e-05 | 181 | 96 | 5 | 8950844b3e65c7028d80da5787ae2ce509c3d52d | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 4.53e-05 | 181 | 96 | 5 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.65e-05 | 182 | 96 | 5 | d1c3cc2942faec7527a3c25869fd65c17899e5e4 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-05 | 182 | 96 | 5 | 81279877b920b5a1bc991a07d3031d6458700fe3 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.65e-05 | 182 | 96 | 5 | 92f83f29e358000cd86a709eb8b6199761ffe8bd | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-brush_cell_of_trachebronchial_tree-Tuft-Tuft_L.0.7.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.65e-05 | 182 | 96 | 5 | 02baca9a72c7b559c3e452693b3b134af804c868 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.77e-05 | 183 | 96 | 5 | b1336eac5adbffade4cef3e0ce3de75a781ae365 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|lymph-node_spleen / Manually curated celltypes from each tissue | 4.77e-05 | 183 | 96 | 5 | 6c55fd737ed31f5b1aa41dc4dba7240521c19022 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-F_(Ciliated)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.77e-05 | 183 | 96 | 5 | cc57dcb59c68d68a546dc108dd9e009b2aab8da5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_KLHL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.77e-05 | 183 | 96 | 5 | 439b1d1373b7cc73d65f3b59037a6def7cf8f4ba | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.90e-05 | 184 | 96 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 184 | 96 | 5 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 4.90e-05 | 184 | 96 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 184 | 96 | 5 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 184 | 96 | 5 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.03e-05 | 185 | 96 | 5 | ae53aa2ecfe418a5dbd7d963a995bc06dab94f56 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 5.03e-05 | 185 | 96 | 5 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.03e-05 | 185 | 96 | 5 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.16e-05 | 186 | 96 | 5 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 186 | 96 | 5 | 29c79b5a29907d4f3f87ad2ca04840c0f15b7d4e | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-05 | 186 | 96 | 5 | f5468e03321ea2083e223eb0d92c3a9307039569 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-05 | 186 | 96 | 5 | e152bdd837366e3e0b8bcfdb4d53f0685f2e803a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-05 | 186 | 96 | 5 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|Epithelial_cells / Location, Cell class and cell subclass | 5.29e-05 | 187 | 96 | 5 | 3cea677279e71fdb9879530dea10a5e6393beacd | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 187 | 96 | 5 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 5.29e-05 | 187 | 96 | 5 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS3|tumor_Lung / Location, Cell class and cell subclass | 5.43e-05 | 188 | 96 | 5 | 26326b4e298e33f9ba393fc632238aa8c54b1ea3 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.43e-05 | 188 | 96 | 5 | 72cbfe9dc0583dbeafa6cb0945fa370d0c808284 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.56e-05 | 189 | 96 | 5 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.70e-05 | 190 | 96 | 5 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 5.70e-05 | 190 | 96 | 5 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.70e-05 | 190 | 96 | 5 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.70e-05 | 190 | 96 | 5 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 5.70e-05 | 190 | 96 | 5 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.70e-05 | 190 | 96 | 5 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 5.85e-05 | 191 | 96 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-05 | 191 | 96 | 5 | c72e62cf5b45c04ee5e7719db31f917c4f76b1e4 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.85e-05 | 191 | 96 | 5 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 5.99e-05 | 192 | 96 | 5 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | multiciliated|World / shred by cell class for turbinate | 5.99e-05 | 192 | 96 | 5 | 0f89ea0deb651ca11531c51ee94e0233608d22ea | |
| ToppCell | Bronchial_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.14e-05 | 193 | 96 | 5 | 3e693ac4c92576e3f2c9efdd3f1d96d3d336e260 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-05 | 193 | 96 | 5 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 193 | 96 | 5 | ca7c0a4ceb05bced90f6cdc53d278e547fb241e9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-05 | 193 | 96 | 5 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-05 | 193 | 96 | 5 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-05 | 193 | 96 | 5 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-05 | 193 | 96 | 5 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.14e-05 | 193 | 96 | 5 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-05 | 193 | 96 | 5 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-05 | 193 | 96 | 5 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-05 | 193 | 96 | 5 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.14e-05 | 193 | 96 | 5 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 6.14e-05 | 193 | 96 | 5 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | 3'-Distal_airway|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.30e-05 | 194 | 96 | 5 | e9ff4398e880d13894e52c0ba9cf19a7662c248b | |
| ToppCell | RV-09._Endothelium_I|RV / Chamber and Cluster_Paper | 6.30e-05 | 194 | 96 | 5 | 7b408096e717f2327c12aea35a8d5fc4621d3b06 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-05 | 194 | 96 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.30e-05 | 194 | 96 | 5 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.30e-05 | 194 | 96 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 6.30e-05 | 194 | 96 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-05 | 195 | 96 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 6.45e-05 | 195 | 96 | 5 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| Disease | cortical surface area measurement | THSD4 ZNF474 MYCBP2 MFHAS1 SVEP1 PHC2 NCOR1 FBN2 CD28 MDC1 SLC4A10 NAV3 AFF1 MACF1 PAPPA MTCL1 SETD3 PDZD2 | 1.53e-07 | 1345 | 92 | 18 | EFO_0010736 |
| Disease | Early Infantile Epileptic Encephalopathy 6 | 9.62e-06 | 2 | 92 | 2 | C4551549 | |
| Disease | cholic acid glucuronide measurement | 2.88e-05 | 3 | 92 | 2 | EFO_0800574 | |
| Disease | anxiety disorder (implicated_via_orthology) | 4.33e-05 | 22 | 92 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | X-25937 measurement | 5.75e-05 | 4 | 92 | 2 | EFO_0800937 | |
| Disease | vital capacity | PHACTR2 ZNF474 RANBP3 PCLO SVEP1 NCOR1 UBXN7 VRTN NCOA1 AFF1 CCAR2 MTCL1 PDZD2 | 1.18e-04 | 1236 | 92 | 13 | EFO_0004312 |
| Disease | neuroimaging measurement | THSD4 ZNF474 NCOR1 AMER2 FBN2 SLC4A10 NAV3 AFF1 MACF1 PAPPA SETD3 FOXJ1 | 1.21e-04 | 1069 | 92 | 12 | EFO_0004346 |
| Disease | triacylglycerol 58:10 measurement | 1.64e-04 | 34 | 92 | 3 | EFO_0010437 | |
| Disease | cortical thickness | THSD4 ZNF474 MYCBP2 SRGAP2 FBN2 NAV3 AFF1 MACF1 MTCL1 SETD3 PDZD2 FOXC2 | 1.76e-04 | 1113 | 92 | 12 | EFO_0004840 |
| Disease | X-24574 measurement | 2.00e-04 | 7 | 92 | 2 | EFO_0800897 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 2.66e-04 | 8 | 92 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 2.66e-04 | 8 | 92 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 2.66e-04 | 8 | 92 | 2 | C0338479 | |
| Disease | Myoclonic Encephalopathy | 2.66e-04 | 8 | 92 | 2 | C0438414 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 2.66e-04 | 8 | 92 | 2 | C0751120 | |
| Disease | deoxycholic acid glucuronide measurement | 2.66e-04 | 8 | 92 | 2 | EFO_0800575 | |
| Disease | Myoclonic Absence Epilepsy | 2.66e-04 | 8 | 92 | 2 | C0393703 | |
| Disease | brain measurement, neuroimaging measurement | 3.27e-04 | 550 | 92 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | Myoclonic Epilepsy | 3.41e-04 | 9 | 92 | 2 | C0014550 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 3.41e-04 | 9 | 92 | 2 | C3502809 | |
| Disease | Epilepsy, Myoclonic, Infantile | 4.26e-04 | 10 | 92 | 2 | C0917800 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 4.26e-04 | 10 | 92 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Disorders of Intracellular Cobalamin Metabolism | 4.26e-04 | 10 | 92 | 2 | cv:CN043592 | |
| Disease | Dravet syndrome (implicated_via_orthology) | 4.26e-04 | 10 | 92 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 4.26e-04 | 10 | 92 | 2 | EFO_0022090 | |
| Disease | Primary Ciliary Dyskinesia | 4.31e-04 | 47 | 92 | 3 | C4551720 | |
| Disease | fatty acid measurement | 4.36e-04 | 436 | 92 | 7 | EFO_0005110 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 5.19e-04 | 11 | 92 | 2 | EFO_0801531 | |
| Disease | Myoclonic Astatic Epilepsy | 5.19e-04 | 11 | 92 | 2 | C0393702 | |
| Disease | eye morphology measurement | 6.14e-04 | 218 | 92 | 5 | EFO_0007858 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 6.22e-04 | 12 | 92 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 6.22e-04 | 12 | 92 | 2 | EFO_0800291 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 7.33e-04 | 13 | 92 | 2 | EFO_0800293 | |
| Disease | Infantile Severe Myoclonic Epilepsy | 7.33e-04 | 13 | 92 | 2 | C0751122 | |
| Disease | X-19141 measurement | 7.33e-04 | 13 | 92 | 2 | EFO_0800799 | |
| Disease | forced expiratory volume | 8.02e-04 | 789 | 92 | 9 | EFO_0004314 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 8.54e-04 | 14 | 92 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 8.54e-04 | 14 | 92 | 2 | EFO_0800283 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 9.99e-04 | 243 | 92 | 5 | EFO_0004612, EFO_0020944 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 1.42e-03 | 18 | 92 | 2 | EFO_0800288 | |
| Disease | prion disease | 1.59e-03 | 19 | 92 | 2 | EFO_0004720 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 1.59e-03 | 19 | 92 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | etiocholanolone glucuronide measurement | 1.59e-03 | 19 | 92 | 2 | EFO_0800362 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.75e-03 | 276 | 92 | 5 | EFO_0004612, EFO_0020943 | |
| Disease | androsterone glucuronide measurement | 1.76e-03 | 20 | 92 | 2 | EFO_0800317 | |
| Disease | testosterone measurement | DENND4A SPEM3 SHROOM4 FBN2 RIN2 UGT2B15 UGT2B17 NCOA1 AFF1 MACF1 JPT2 | 2.05e-03 | 1275 | 92 | 11 | EFO_0004908 |
| Disease | X-24947 measurement | 2.13e-03 | 22 | 92 | 2 | EFO_0800910 | |
| Disease | snoring measurement | 2.33e-03 | 84 | 92 | 3 | EFO_0008341 | |
| Disease | response to anticonvulsant | 2.41e-03 | 85 | 92 | 3 | GO_0036277 | |
| Disease | unipolar depression, response to selective serotonin reuptake inhibitor | 2.54e-03 | 24 | 92 | 2 | EFO_0003761, EFO_0005658 | |
| Disease | response to radiation | 2.66e-03 | 88 | 92 | 3 | GO_0009314 | |
| Disease | epiandrosterone sulfate measurement | 2.75e-03 | 25 | 92 | 2 | EFO_0021120 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.78e-03 | 447 | 92 | 6 | EFO_0000694, MONDO_0100096 | |
| Disease | ergothioneine measurement | 2.98e-03 | 26 | 92 | 2 | EFO_0021163 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGKSTKPGAAPTEHK | 786 | Q8N163 | |
| EAGPSCDKHVPGPGK | 391 | Q8N7J2 | |
| CDKHVPGPGKPALSK | 396 | Q8N7J2 | |
| PKKAGLHPPDSQASG | 201 | Q9NQ75 | |
| KGKHLCPSPLFPGPS | 136 | P10747 | |
| CPTAPQKENKGPGLT | 361 | A5X5Y0 | |
| HPPAGDGKKPSIAAV | 601 | Q9H9G7 | |
| THPPAGDGKKPSIAA | 591 | Q9HCK5 | |
| VSCIKKASGPNPGPD | 1091 | Q8WXS8 | |
| PSKGESPPHTFCKVD | 166 | Q7Z401 | |
| HGQAPSAGLPSQKPK | 151 | Q9H6Z4 | |
| PACELKPPFHSLDGG | 271 | P78413 | |
| SPHKCLTPKAGGGAT | 1661 | Q9Y4B5 | |
| APSLKKCPGGFSQHP | 551 | Q2M385 | |
| PSQAEPASHKGPKDA | 71 | O00763 | |
| PGAPCAIKISKSPDG | 1891 | P51610 | |
| PPCSALKGKSHKPVG | 521 | P23352 | |
| PRPPCAKPHKEGTGQ | 56 | Q6PKG0 | |
| GSLAAPIDHKPCSAP | 1731 | Q14676 | |
| KCLKRGSPNPHAFPG | 986 | Q9Y4C4 | |
| PKIKKGLSPHCNGSD | 451 | Q9H3C7 | |
| GPFPACLKASADGHP | 161 | Q9GZZ0 | |
| NPHLPKKRGSSCQGL | 701 | Q6PRD1 | |
| PVLGPDGKTHGNKCA | 181 | Q9NQ38 | |
| TAPHPKLAPTSQKGG | 671 | P46020 | |
| PRSHNKVLNPPGGKS | 171 | Q9H910 | |
| KKGATLPQHIPAGCS | 351 | Q9UBK8 | |
| LPGNHVPNGCAADPK | 576 | B1AK53 | |
| TLHGSPSAKAKQPPE | 711 | Q9Y6V0 | |
| ISSPGKKGAAHPDPS | 1236 | O15018 | |
| PASPKLPHNAGDCGS | 1741 | Q8IVL0 | |
| KDGSLPPELSCIPSH | 1021 | Q5T1M5 | |
| DHPGQHGKTPSPQKL | 61 | E9PQR5 | |
| SKGAPATPHLADAPK | 191 | Q99958 | |
| CANKVTGKTPAPPAG | 181 | Q9NX70 | |
| KSPVPPKGATAGASH | 171 | O75167 | |
| APKHKSCGDPGPGND | 606 | Q13219 | |
| PGAAVLPCSKSHPKA | 1946 | Q9UPN3 | |
| KHPSKPDPSGECNPD | 156 | Q09028 | |
| QKPSVPSHGPKTPSC | 21 | X6R8D5 | |
| PSHGPKTPSCKGVKA | 26 | X6R8D5 | |
| SPKDIGHKVAPGVPS | 146 | Q4G0P3 | |
| EPLKASQCSPGPEGH | 926 | Q6AI39 | |
| PHCRKPSGSGDQSKP | 61 | Q8TBM8 | |
| GPLSSCHKLVDPQGP | 3871 | Q9Y6R7 | |
| PSPCDSKSGGHTPKA | 61 | O00512 | |
| PGKCTLHLGIEPPDS | 4051 | Q8N3K9 | |
| GSKPCHIQAVDPSGP | 346 | Q8TB45 | |
| GHKEAPSPTCPDLGA | 176 | O00257 | |
| AADPACLGQPHTPGK | 76 | Q92949 | |
| PKQGKKENGPPHSHT | 76 | Q99741 | |
| GPSPEHHKPLCKGSP | 276 | Q96PX6 | |
| SNGLCPEILGKPHDP | 106 | Q5VTH2 | |
| VKCVTPLHSKPGAPS | 776 | Q6UXX5 | |
| DVKRQHKCPGPTSGP | 31 | Q12912 | |
| KTTEVPTEPGKHPCG | 171 | Q5JRC9 | |
| GPECDHPKIKPSSSA | 656 | P22681 | |
| PLPGTAQYKKICPHG | 2426 | P35556 | |
| DHPGQHGKTPSPQKL | 61 | E9PJ23 | |
| GGASLDLKACPPKPS | 3921 | Q8TE73 | |
| KSKSPPSAGPLVVHC | 1081 | P28827 | |
| AAAPTGLQPPGCKDH | 136 | Q5VT97 | |
| CLHKINGKPLPGATP | 61 | Q9NX07 | |
| PANPDSHKRKGSPCD | 11 | Q15788 | |
| RSPKKPTNCHPGLGT | 91 | Q8NET5 | |
| GKHEAPSSPISGQPC | 151 | O75376 | |
| EGDPSPHSGGVCKPK | 2311 | O75376 | |
| KPPDCDPKKVHPGSS | 1711 | Q15858 | |
| ELLQKCSSPAPGPGK | 31 | Q86TU7 | |
| HSSHKGKKSPCPPTG | 451 | Q9ULL8 | |
| GKKSPCPPTGGTHDQ | 456 | Q9ULL8 | |
| CGENGPAHPLPSKTK | 1611 | Q9C0D5 | |
| PHCPAGPKGKQLEGT | 4636 | O75592 | |
| PIKCKAPGNPENGHS | 1786 | Q4LDE5 | |
| SKPPDCDPNKVNPGS | 1736 | P35498 | |
| EAPHPGKRSCQKSPA | 576 | P51825 | |
| EPGHAEGILGKPCPK | 21 | Q9BQY6 | |
| NKHGNVALPGTKPTP | 341 | Q8WYP3 | |
| APAPAASQPSGCGKH | 11 | Q96I15 | |
| PLQCPTANLHKPGGS | 406 | Q8IXK0 | |
| TGPGIPHINGKPACD | 106 | O75970 | |
| QKHCPAVLPSGGLPA | 46 | O76050 | |
| HKSPGLVQTSGLPKC | 891 | A0A1B0GUW6 | |
| PKHLPSCPDKGFTDK | 226 | Q6P1M0 | |
| GSQNDGKHLCPPGKP | 131 | Q7RTT5 | |
| GKHLCPPGKPSTSEK | 136 | Q7RTT5 | |
| TSPCGMKQRHEKGPP | 296 | Q6U841 | |
| PKEGPDKCSISGHGS | 886 | O75044 | |
| TQCKSPGSPHNPKTP | 1126 | Q6IQ55 | |
| KPCAKVGAQPPTGAE | 166 | Q8N554 | |
| TPVTGVSPKKAHPCE | 81 | E7ETH6 | |
| HGQLDGLSSSPPKKC | 261 | O94888 | |
| SCKPKGEGPRAPHSN | 186 | Q6S9Z5 | |
| PQSPGGNICHLGAPK | 21 | Q9H609 | |
| KKHPAAPPGGRPFTC | 441 | Q6NUN9 | |
| PAGNSLPTEAPKKHC | 966 | P52746 | |
| PKKHCFDPVPPAGNS | 976 | P52746 | |
| DFVGGLHCKPAKPLP | 276 | P54855 | |
| PPSQQSCHLKPCGAK | 901 | Q6ZMP0 | |
| KHELLGSGTCPALPP | 351 | Q9H8Y1 | |
| CSKDAKVPSPPPGHK | 386 | P11387 | |
| DFVGGLHCKPAKPLP | 276 | O75795 | |
| HPITKPGGSAKDAAP | 456 | A6NN73 | |
| ICPDPSAKNGSKGPL | 1716 | E9PAV3 |